by Microbix | Mar 11, 2024 | News Releases
HPV-related Tissue-Sample Mimics for QC of histology and PCR analyses MISSISSAUGA, CANADA, March 11, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is presenting results of...
by Microbix | Mar 7, 2024 | News Releases
ISO 13485:2016 Medical Devices Certification Attained TORONTO, December 24, 2018 – Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, announces that it has attained the ISO 13485:2016 Medical Devices...
by Microbix | Feb 14, 2024 | News Releases
Record Revenues of $8.4 million and Record Net Income of $2.5 million MISSISSAUGA, CANADA, February 14, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its first...
by Microbix | Feb 11, 2024 | News Releases
Microbix will be hosting a virtual AGM on March 27, 2024, at 1:00 pm. The online link will allow shareholders to listen to the AGM and view a CEO presentation via Zoom. Shareholders without up-to-date computer access can listen-in via telephone by using the...
by Microbix | Feb 7, 2024 | News Releases
Results Release and Webinar Discussion on Morning of February 14, 2024 MISSISSAUGA, CANADA, February 7, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it expects to file...
Request a Quote
+1803294983432
customer.service@microbix.com